Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs
Eighty years after the introduction of the first antituberculosis (TB) drug, the treatment of drug-susceptible TB remains very cumbersome, requiring the use of four drugs (isoniazid, rifampicin, ethambutol and pyrazinamide) for two months followed by four months on isoniazid and rifampicin. Two of t...
Main Author: | Catherine Vilchèze |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/10/7/2278 |
Similar Items
-
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3
by: Giulia Degiacomi, et al.
Published: (2020-01-01) -
Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases
by: Makhoba XH, et al.
Published: (2020-08-01) -
Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
by: Hans Carolus, et al.
Published: (2020-11-01) -
Recent Progress in the Development of New Antimalarial Drugs with Novel Targets
by: Belete TM
Published: (2020-09-01) -
Mycobacterium tuberculosis Molecular Determinants of Infection, Survival Strategies, and Vulnerable Targets
by: Davide M. Ferraris, et al.
Published: (2018-02-01)